Webinar | February 3, 2021

Advances In Cell And Gene Therapy Analytics - How To Use Maurice To Characterize AAVs And LNPs

Source: bio-techne

Learn how Maurice can be used to measure surface charge of an LNP-based mRNA vaccine for confirmation of LNP identity in a manufacturing setting, and for stability assessment for process and formulation development. You will also learn how to assess purity, stability and concentration of AAVs.

Speakers:

  • John Loughney, Director, Vaccine Analytical Research & Development, Merck & Co., Inc.
  • Chris Heger, Director, Applications Science, Analytical Solutions, Bio-Techne
access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

bio-techne